StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) shareholders

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 27, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3083% above fair value
$267.14−5.56 (-2.04%)

Close on Nov 19, 2026Market cap $643.09BP/E 40.5Yield 1.92%

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
74.8%
1.80B of 2.41B shares
Institutional holders
4,673
222 new, 119 sold out
Net institutional buying
42M
In Q2 2026
Insider trades, 12 months
1 buys · 29 sales
Net sold $154.13M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.186,308,3417.70%13G (passive) amendmentDec 31, 2023
Vanguard Capital Management180,631,2287.49%13G (passive)Mar 31, 2026
State Street Corporation–5.52%13G (passive) amendmentDec 31, 2023

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of JNJValueChange% of portfolio
BlackRock, Inc.212,098,2648.81%$53.87B−1,287,2820.80%
Vanguard Capital Management LLC157,226,3746.53%$39.93B+621,0040.85%
State Street Corp133,776,0255.56%$33.98B+299,7371.01%
Vanguard Portfolio Management LLC64,370,8162.67%$16.35B+856,3800.74%
Geode Capital Management, LLC59,086,4172.45%$14.97B−78,4450.80%
JPMorgan Chase & Co58,301,6092.42%$15.07B−4,794,7350.83%
Morgan Stanley44,808,2541.86%$11.38B+87,0870.60%
Norges Bank31,825,0841.32%$8.08BNew0.81%
State Farm Mutual Automobile Insurance Co31,590,9521.31%$8.02B–5.49%
Northern Trust Corp28,792,0641.20%$7.31B−527,6050.85%
Bank Of America Corp /De/23,438,1410.97%$5.95B−2,078,5560.38%
Price T Rowe Associates Inc /Md/22,996,8780.96%$5.84B+6,505,7450.58%
FMR LLC22,595,5660.94%$5.74B−2,176,2620.25%
Wellington Management Group Llp22,588,6960.94%$5.74B+2,513,3210.99%
Bank of New York Mellon Corp21,683,3470.90%$5.51B−138,6150.90%
Goldman Sachs Group Inc19,722,5440.82%$5.01B+1,665,4970.43%
Legal & General Group Plc19,286,9040.80%$4.90B−60,9581.02%
Charles Schwab Investment Management Inc19,126,1650.79%$4.86B−51,0540.65%
UBS Asset Management Americas Inc18,416,1230.77%$4.68B−1,211,9900.85%
Wells Fargo & Company/Mn17,374,4330.72%$4.41B+448,9790.71%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20264,6731.80B74.8%222 / 20521908 / 119103M61M
Q1 20264,6471.78B73.8%302 / 17122161 / 124344M113M
Q4 20254,5391.79B74.4%543 / 16541935 / 106129M129M
Q3 20254,1961.80B74.7%295 / 17041800 / 120134M105M
Q2 20254,0921.77B73.6%176 / 16351889 / 18181M50M
Q1 20254,1571.74B72.5%255 / 17071842 / 14792M77M
Q4 20244,1121.74B72.3%470 / 13571937 / 17793M95M
Q3 20243,8911.76B72.9%230 / 15591735 / 104267M48M
Q2 20243,8111.74B72.2%161 / 15171791 / 15384M137M
Q1 20243,8571.80B74.8%163 / 15731752 / 128109M54M
Q4 20233,8751.75B72.6%378 / 13031881 / 126133M49M
Q3 20233,6841.67B69.3%151 / 12222004 / 18129M175M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

1,504 funds held JNJ in Q2 2026, 56% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of JNJValue% of fundAs of
Vanguard Total Stock Market Index Fund76,421,6243.17%$19.41B0.84%Jun 30, 2026
Vanguard 500 Index Fund62,378,8022.59%$15.84B0.95%Jun 30, 2026
iShares Core S&P 500 ETF33,111,7501.38%$8.41B0.95%Jun 30, 2026
Fidelity 500 Index Fund30,839,5341.28%$6.95B0.84%May 31, 2026
Vanguard Value Index Fund22,911,0230.95%$5.82B2.29%Jun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF17,006,1700.71%$4.32B10.64%Jun 30, 2026
Vanguard Dividend Appreciation Index Fund13,619,9030.57%$3.49B2.67%Jul 31, 2026
Vanguard Institutional Index Fund13,067,9150.54%$3.32B0.95%Jun 30, 2026
Vanguard High Dividend Yield Index Fund9,702,1270.40%$2.49B2.51%Jul 31, 2026
Washington Mutual Investors Fund9,490,5610.39%$2.43B1.12%Jul 31, 2026
Vanguard Health Care Fund7,191,5660.30%$1.84B4.83%Jul 31, 2026
Vanguard Health Care Index Fund7,135,5560.30%$1.61B8.47%May 31, 2026
Columbia Dividend Income Fund7,113,9800.30%$1.60B3.40%May 31, 2026
JPMorgan Large Cap Growth Fund6,791,6000.28%$1.72B1.42%Jun 30, 2026
MFS Value Fund6,243,5030.26%$1.41B2.75%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Joaquin DuatoCEO and Chairman of the Board, Director307,8370.01%Aug 14, 2026
Elizabeth ForminardEVP, Chief Legal Officer16,9940.00%Nov 13, 2026
Timothy SchmidEVP, WW Chair, MedTech48,7780.00%Sep 4, 2026
Thomas CavanaughEVP WW Chair, Innovative Med.4990.00%Sep 1, 2026
Jennifer L. TaubertEVP, WWC. Innovative Medicine209,4510.01%Aug 18, 2026
Vanessa BroadhurstEVP, Global Corp Affairs23,0030.00%Jul 21, 2026
Kathryn E. WengelEVP, Chief TO and Risk Officer124,6590.01%Jun 12, 2026
John C. ReedEVP, Innovative Medicine, R&D35,9130.00%May 4, 2026
Robert J. DeckerVP Corporate Controller28,5370.00%Mar 3, 2026
Joseph J. WolkExec VP, CFO109,9690.00%Feb 18, 2026
James D. SwansonEVP, CIO46,2190.00%Feb 18, 2026
Kristen MulhollandEVP, Chief HR Officer19,6780.00%Feb 18, 2026
Eugene A. WoodsDirector2500.00%Sep 10, 2026
Marillyn A. HewsonDirector3,0000.00%Sep 10, 2026
Daniel E. PintoDirector0–Sep 10, 2026
John G. MorikisDirector1,8490.00%Apr 27, 2026
Hubert JolyDirector5,0000.00%Apr 27, 2026
Mark B. McClellanDirector––Apr 27, 2026
Mary C. BeckerleDirector––Apr 27, 2026
Mark A. WeinbergerDirector1,0000.00%Apr 27, 2026
Paula A. JohnsonDirector1910.00%Apr 27, 2026
Nadja WestDirector––Apr 27, 2026
Jennifer A. DoudnaDirector––Apr 27, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Elizabeth Forminard
EVP, Chief Legal Officer
Nov 12, 2026Sale−13,072$284.39$3.72M16,994
Elizabeth Forminard
EVP, Chief Legal Officer
Nov 12, 2026Option exercise+13,072$151.41$1.98M30,066
Timothy Schmid
EVP, WW Chair, MedTech
Sep 2, 2026Option exercise+22,527$151.41$3.41M47,974
Timothy Schmid
EVP, WW Chair, MedTech
Sep 2, 2026Option exercise+11,070$131.94$1.46M36,517
Timothy Schmid
EVP, WW Chair, MedTech
Sep 2, 2026Sale−11,070$274.74$3.04M25,447
Timothy Schmid
EVP, WW Chair, MedTech
Sep 2, 2026Sale−22,527$274.74$6.19M25,447
Jennifer L. Taubert
EVP, WWC. Innovative Medicine
Aug 17, 2026Option exercise+15,000$115.67$1.74M209,451
Jennifer L. Taubert
EVP, WWC. Innovative Medicine
Aug 17, 2026Sale−15,000$263.36$3.95M194,451
Joaquin Duato
CEO and Chairman of the Board, Director
Aug 13, 2026Sale−102,315$261.00$26.70M275,967
Joaquin Duato
CEO and Chairman of the Board, Director
Aug 13, 2026Option exercise+123,291$115.67$14.26M399,258
Joaquin Duato
CEO and Chairman of the Board, Director
Aug 13, 2026Sale−20,976$262.00$5.50M378,282
Elizabeth Forminard
EVP, Chief Legal Officer
Aug 6, 2026Sale−9,344$257.76$2.41M23,568
Elizabeth Forminard
EVP, Chief Legal Officer
Aug 6, 2026Option exercise+9,344$131.94$1.23M32,912
Elizabeth Forminard
EVP, Chief Legal Officer
Aug 6, 2026Sale−6,574$255.93$1.68M16,994
Joaquin Duato
CEO and Chairman of the Board, Director
Aug 5, 2026Sale−6,523$258.74$1.69M275,967
Joaquin Duato
CEO and Chairman of the Board, Director
Aug 5, 2026Sale−41,957$258.06$10.83M282,490
Vanessa Broadhurst
EVP, Global Corp Affairs
Jul 20, 2026Sale−23,054$251.27$5.79M23,003
Vanessa Broadhurst
EVP, Global Corp Affairs
Jul 20, 2026Option exercise+11,925$131.94$1.57M46,057
Vanessa Broadhurst
EVP, Global Corp Affairs
Jul 20, 2026Option exercise+11,129$129.51$1.44M34,132
Kathryn E. Wengel
EVP, Chief TO and Risk Officer
Jun 11, 2026Option exercise+10,000$115.67$1.16M124,288
Kathryn E. Wengel
EVP, Chief TO and Risk Officer
Jun 11, 2026Sale−10,000$241.15$2.41M114,288
John C. Reed
EVP, Innovative Medicine, R&D
May 1, 2026Option exercise+25,255––35,913
John C. Reed
EVP, Innovative Medicine, R&D
May 1, 2026Tax withholding−11,002$229.85$2.53M24,911
Robert J. Decker
VP Corporate Controller
Feb 27, 2026Option exercise+4,075$115.67$471.36K27,757
Robert J. Decker
VP Corporate Controller
Feb 27, 2026Sale−4,075$247.87$1.01M23,682
Timothy Schmid
EVP, WW Chair, MedTech
Feb 20, 2026Sale−1,322$245.66$324.76K25,447
Timothy Schmid
EVP, WW Chair, MedTech
Feb 18, 2026Option exercise+13,625$115.67$1.58M40,394
Timothy Schmid
EVP, WW Chair, MedTech
Feb 18, 2026Sale−13,625$244.20$3.33M26,769
Timothy Schmid
EVP, WW Chair, MedTech
Feb 18, 2026Option exercise+8,998$129.51$1.17M35,767
Timothy Schmid
EVP, WW Chair, MedTech
Feb 18, 2026Sale−8,998$244.53$2.20M26,769
John C. Reed
EVP, Innovative Medicine, R&D
Feb 17, 2026Option exercise+21,721$157.92$3.43M34,662
John C. Reed
EVP, Innovative Medicine, R&D
Feb 17, 2026Sale−21,721$243.00$5.28M12,941
John C. Reed
EVP, Innovative Medicine, R&D
Feb 17, 2026Sale−2,283$243.00$554.77K10,658
John C. Reed
EVP, Innovative Medicine, R&D
Feb 17, 2026Sale−29,927$243.00$7.27M12,941
John C. Reed
EVP, Innovative Medicine, R&D
Feb 17, 2026Option exercise+29,927$156.15$4.67M42,868
Joseph J. Wolk
Exec VP, CFO
Feb 17, 2026Sale−12,066$242.87$2.93M38,961
Joseph J. Wolk
Exec VP, CFO
Feb 17, 2026Option exercise+33,386$131.94$4.40M72,347
Joseph J. Wolk
Exec VP, CFO
Feb 17, 2026Sale−33,386$242.75$8.10M38,961
Joseph J. Wolk
Exec VP, CFO
Feb 17, 2026Sale−24,961$242.68$6.06M14,000
Joseph J. Wolk
Exec VP, CFO
Feb 17, 2026Sale−19,241$242.99$4.68M38,961
Joseph J. Wolk
Exec VP, CFO
Feb 17, 2026Option exercise+19,241$115.67$2.23M58,202
Joseph J. Wolk
Exec VP, CFO
Feb 17, 2026Option exercise+12,066$129.51$1.56M51,027
Vanessa Broadhurst
EVP, Global Corp Affairs
Feb 17, 2026Sale−6,197$243.39$1.51M23,003
James D. Swanson
EVP, CIO
Feb 17, 2026Option exercise+20,521$164.62$3.38M46,219
James D. Swanson
EVP, CIO
Feb 17, 2026Sale−20,521$242.70$4.98M25,698
Elizabeth Forminard
EVP, Chief Legal Officer
Feb 15, 2026Option exercise+961––23,541
Elizabeth Forminard
EVP, Chief Legal Officer
Feb 15, 2026Tax withholding−492$243.45$119.78K23,049
Elizabeth Forminard
EVP, Chief Legal Officer
Feb 15, 2026Option exercise+1,063––24,112
Elizabeth Forminard
EVP, Chief Legal Officer
Feb 15, 2026Tax withholding−544$243.45$132.44K23,568
John C. Reed
EVP, Innovative Medicine, R&D
Feb 15, 2026Tax withholding−385$243.45$93.73K11,622
John C. Reed
EVP, Innovative Medicine, R&D
Feb 15, 2026Tax withholding−528$243.45$128.54K12,941
John C. Reed
EVP, Innovative Medicine, R&D
Feb 15, 2026Option exercise+1,847––13,469
John C. Reed
EVP, Innovative Medicine, R&D
Feb 15, 2026Option exercise+1,349––12,007
Jennifer L. Taubert
EVP, WWC. Innovative Medicine
Feb 15, 2026Tax withholding−945$243.45$230.06K194,451
Jennifer L. Taubert
EVP, WWC. Innovative Medicine
Feb 15, 2026Option exercise+1,847––195,396
Jennifer L. Taubert
EVP, WWC. Innovative Medicine
Feb 15, 2026Tax withholding−816$243.45$198.66K193,549
Jennifer L. Taubert
EVP, WWC. Innovative Medicine
Feb 15, 2026Option exercise+1,594––194,365
Timothy Schmid
EVP, WW Chair, MedTech
Feb 15, 2026Option exercise+1,028––26,206
Timothy Schmid
EVP, WW Chair, MedTech
Feb 15, 2026Tax withholding−15$243.45$3.65K26,191
Timothy Schmid
EVP, WW Chair, MedTech
Feb 15, 2026Option exercise+1,026––27,217

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.71%
17M shares short
Days to cover
2.4
At 7M shares a day
Change since last report
+1.8%
From 17M shares
Short volume, 20 days
32.3%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Johnson & Johnson's stock actually held short. Settlement fails (shares not delivered on time) peaked at 89,357 shares on Sep 21, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Timothy Schmid
Officer
Sep 2, 202633,597$9.23MSep 2, 2026Stock Option Exercise
Jennifer L. Taubert
Officer
Aug 17, 202615,000$3.95MAug 17, 2026Stock Option Exercise
Joaquin Duato
Officer, Director
Aug 13, 2026123,291$32.20MAug 13, 2026Stock Option Exercise
Elizabeth Forminard
Officer
Aug 6, 202615,918$4.09MAug 6, 2026Stock Option Exercise
Joaquin Duato
CEO, Chariman
Aug 5, 202648,480$12.36MAug 5, 2026Executive compensation
Vanessa Broadhurst
Officer
Jul 20, 202623,054$5.79MJul 20, 2026Stock Option Exercise
Kathryn E. Wengel
Officer
Jun 11, 202610,000$2.40MJun 11, 2026Stock Option Exercise
Robert J. Decker
Officer
Feb 27, 20264,075$1.01MFeb 27, 2026Option Granted - 02/13/2017
Timothy Schmid
Officer
Feb 20, 20261,322$324.76KFeb 20, 2026Restricted Stock Vesting
Timothy Schmid
Officer
Feb 18, 202622,623$5.53MFeb 18, 2026Option Granted - 02/13/2017
Vanessa Broadhurst
Officer
Feb 17, 20266,197$1.51MFeb 17, 2026Restricted Stock Vesting
James D. Swanson
Officer
Feb 17, 202620,521$4.98MFeb 17, 2026Options Granted - 02/08/2021
Joseph J. Wolk
Officer
Feb 17, 202689,654$21.77MFeb 17, 2026Restricted Stock Vesting
John C. Reed
Officer
Feb 17, 202653,931$13.11MFeb 17, 2026Restricted Stock Vesting
James D. Swanson
Officer
Feb 13, 202641,559$10.13MFeb 13, 2026Option Granted - 02/14/2022

Congress trades

40 trades in Johnson & Johnson reported by 14 members of the House

MemberTypeTradedAmountFiled
Thomas H. Kean Jr
NJ07
Sold (part)Sep 30, 2026$1K–15KOct 30, 2026
Lloyd Doggett
TX37
BoughtSep 8, 2026$1K–15KOct 5, 2026
Thomas H. Kean Jr
NJ07
Sold (part)Aug 27, 2026$1K–15KSep 12, 2026
Richard Dean Dr McCormick
GA06
SoldJul 30, 2026$1K–15KAug 14, 2026
Thomas H. Kean Jr
NJ07
Sold (part)Jun 29, 2026$1K–15KJul 15, 2026
Lloyd Doggett
TX37
BoughtJun 9, 2026$1K–15KJul 6, 2026
Thomas H. Kean Jr
NJ07
Sold (part)Jun 2, 2026$1K–15KJul 15, 2026
Rohit Khanna
CA17 · child
Sold (part)May 1, 2026$1K–15KJun 9, 2026
Rohit Khanna
CA17 · spouse
BoughtApr 13, 2026$15K–50KMay 11, 2026
Thomas H. Kean Jr
NJ07
Sold (part)Mar 26, 2026$1K–15KApr 13, 2026
Richard Dean Dr McCormick
GA06
Sold (part)Mar 19, 2026$1K–15KApr 7, 2026
Richard Dean Dr McCormick
GA06
Sold (part)Mar 19, 2026$1K–15KApr 7, 2026
Lloyd Doggett
TX37
BoughtMar 10, 2026$1K–15KApr 6, 2026
Thomas H. Kean Jr
NJ07
Sold (part)Jan 23, 2026$15K–50KFeb 19, 2026
Julie Johnson
TX32 · joint account
SoldDec 18, 2025$1K–15KJan 15, 2026
Lloyd Doggett
TX37
BoughtDec 9, 2025$1K–15KJan 2, 2026
Rohit Khanna
CA17 · child
BoughtDec 5, 2025$1K–15KJan 6, 2026
Thomas H. Kean Jr
NJ07
Sold (part)Nov 20, 2025$15K–50KDec 19, 2025
Julie Johnson
TX32 · joint account
Sold (part)Nov 13, 2025$1K–15KDec 11, 2025
Rohit Khanna
CA17 · child
BoughtNov 7, 2025$15K–50KDec 8, 2025
Richard Dean Dr McCormick
GA06
BoughtNov 5, 2025$1K–15KDec 9, 2025
Lisa McClain
MI09 · spouse
SoldOct 31, 2025$1K–15KNov 21, 2025
Lisa McClain
MI09 · spouse
BoughtOct 30, 2025$1K–15KNov 21, 2025
Lisa McClain
MI09 · spouse
SoldOct 30, 2025$1K–15KNov 21, 2025
Jared Moskowitz
FL23 · child
Sold (part)Oct 10, 2025$1K–15KNov 22, 2025
Jared Moskowitz
FL23 · child
Sold (part)Oct 10, 2025$1K–15KNov 22, 2025
Valerie Hoyle
OR04 · spouse
SoldSep 23, 2025$1K–15KOct 10, 2025
Kelly Louise Morrison
MN03
Sold (part)Aug 19, 2025$1K–15KSep 11, 2025
Julie Johnson
TX32 · joint account
Sold (part)Aug 14, 2025$1K–15KSep 11, 2025
Lisa McClain
MI09 · spouse
BoughtAug 4, 2025$1K–15KSep 12, 2025
Thomas H. Kean Jr
NJ07
Sold (part)Jul 31, 2025$15K–50KAug 20, 2025
Lisa McClain
MI09 · spouse
SoldJun 24, 2025$1K–15KAug 13, 2025
50 days late
Lisa McClain
MI09 · spouse
BoughtJun 17, 2025$1K–15KAug 13, 2025
57 days late
Scott Scott Franklin
FL18 · joint account
SoldJun 16, 2025$15K–50KJul 14, 2025
Pete Sessions
TX17 · spouse
SoldJun 12, 2025$15K–50KJun 21, 2025
Lloyd Doggett
TX37
BoughtJun 10, 2025$1K–15KJul 7, 2025
Gilbert Cisneros
CA31
BoughtMay 30, 2025$15K–50KJun 6, 2025
Jefferson Shreve
IN06
SoldMay 12, 2025$50K–100KJun 22, 2025
Marjorie Taylor Greene
GA14
BoughtMay 5, 2025$1K–15KMay 6, 2025
Gilbert Cisneros
CA31
Sold (part)Apr 29, 2025$1K–15KMay 6, 2025

See a number that looks wrong?